MedPath

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Phase 3
Not yet recruiting
Conditions
Crohn's Disease
Obesity or Overweight
Interventions
Registration Number
NCT06937099
Lead Sponsor
Eli Lilly and Company
Brief Summary

The main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizumab and concomitantly administered tirzepatide in adult participants with moderately to severely active CD and obesity, or overweight.

The maximum duration of this study is up to 61 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
290
Inclusion Criteria
  • Have had a diagnosis of Crohn's disease (CD) or perianal fistulizing CD established at least 3 months prior to enrollment confirmed by clinical, endoscopic, and histological criteria.

  • Have obesity body mass index 30 kilograms per meter squared (BMI ≥30 kg/m2), or overweight (BMI ≥27 kg/m2 to <30 kg/m2) and in the presence of at least 1 of these weight-related comorbid conditions:

    • hypertension
    • Type 2 diabetes mellitus (T2DM)
    • dyslipidemia
    • obstructive sleep apnea, or
    • cardiovascular disease.
  • Have moderately to severely active CD defined by a CDAI score of at least 220 at baseline.

  • Have a centrally read Simple Endoscopic Score for Crohn's Disease (SES-CD) score ≥6 for patients with ileal-colonic or ≥4 for patients with isolated ileal disease within 21 days before the first dose of study treatment.

  • Have a history of CD involving only or predominantly the colon for greater than or equal to 8 years with a surveillance colonoscopy within 1 year prior to baseline must have documented negative results for colorectal dysplasia and cancer.

  • Have an inadequate response to, loss of response to, or intolerance to:

    • at least one conventional therapy (such as corticosteroids, oral azathioprine (AZA) or 60-mercaptopurine (6-MP), or oral aminosalicylates (for example, mesalamine, sulfasalazine, olsalazine, balsalazide) and/or,
    • at least one advanced therapy for CD (defined as: a biologic or biosimilar medication such as anti-tumor necrosis factor (TNF) antibodies, anti-integrin antibodies, Janus kinase (JAK) inhibitors such as upadacitinib, or anti-interleukin (IL)-12p40 antibodies, for example, ustekinumab).
Exclusion Criteria
  • Have a current diagnosis of Ulcerative Colitis (UC), inflammatory bowel disease-unclassified (formerly known as indeterminate colitis), or primary sclerosing cholangitis.
  • Have more than 2 missing segments of the following 5 segments: terminal ileum, ·right colon, transverse colon, ·left colon, and rectum.
  • Currently have or are suspected to have an abscess.
  • Have a stoma, ileoanal pouch, or ostomy.
  • Have a history of more than 3 small bowel resections, diagnosis of short bowel syndrome, or any intestinal or non-intestinal intra-abdominal surgery within 3 months of baseline.
  • Have a diagnosis of Type 1 Diabetes Mellitus (T1DM) or have insulin-treated T2DM.
  • Have a history of severe hypoglycemia and/or hypoglycemia unawareness within the 6 months prior to screening.
  • Have had more than 5% body weight change in the past 3 months
  • Have a current or recent acute, active infection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mirikizumab + TirzepatideMirikizumabMirikizumab administered intravenously (IV) then Mirikizumab administered subcutaneously (SC). Tirzepatide administered SC.
Mirikizumab + TirzepatideTirzepatideMirikizumab administered intravenously (IV) then Mirikizumab administered subcutaneously (SC). Tirzepatide administered SC.
Mirikizumab + PlaceboMirikizumabMirikizumab administered IV then Mirikizumab administered SC. Placebo administered SC.
Mirikizumab + PlaceboPlaceboMirikizumab administered IV then Mirikizumab administered SC. Placebo administered SC.
Primary Outcome Measures
NameTimeMethod
Percentage of Participants Who Simultaneously Achieve Clinical Remission by Crohn's Disease Activity Index (CDAI), Endoscopic Remission, and at least 10% Weight ReductionWeek 52

Percentage of participants who simultaneously achieve clinical remission by CDAI, endoscopic remission and at least 10% weight reduction.

Secondary Outcome Measures
NameTimeMethod
Percentage of Participants Who Simultaneously Achieve Clinical Remission by CDAI and Endoscopic RemissionWeek 52

Percentage of participants who simultaneously achieve clinical remission by CDAI and endoscopic remission.

Percentage of Participants Who Achieved Maintenance of Clinical Remission by CDAIWeek 52

Percentage of participants who achieve maintenance of clinical remission by CDAI.

Percentage of Participants Who Achieved Maintenance of Endoscopic RemissionWeek 52

Percentage of participants who achieve maintenance of endoscopic remission.

Percentage of Participants Who Achieve at Least a 10% Reduction in Body WeightWeek 52

Percentage of participants who achieve at least a 10% reduction in body weight.

Percentage of Participants Who Achieve Corticosteroid-free Clinical Remission by CDAI Among Participants Who Used Corticosteroids at BaselineWeek 52

Percentage of participants who achieve corticosteroid-free clinical remission by CDAI among participants who used corticosteroids at baseline.

Change from Baseline in Inflammatory Bowel Disease Questionnaire (IBDQ)Baseline, Week 52

Change from baseline in inflammatory bowel disease questionnaire (IBDQ).

Trial Locations

Locations (126)

California Medical Research Associates

🇺🇸

Northridge, California, United States

Precision Clinical Research

🇺🇸

Sunrise, Florida, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

Indiana University Health University Hospital

🇺🇸

Indianapolis, Indiana, United States

Lucida Clinical Trials

🇺🇸

New Bedford, Massachusetts, United States

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

University Gastroenterology - Providence - West River Street

🇺🇸

Providence, Rhode Island, United States

Medizinische Universität Graz

🇦🇹

Graz, Steiermark, Austria

Medizinische Universitaet Innsbruck

🇦🇹

Innsbruck, Tirol, Austria

Medizinische Universität Wien

🇦🇹

Vienna, Wien, Austria

Clinical Chc Montlégia

🇧🇪

Liege, Liège, Belgium

AZORG Campus Aalst-Moorselbaan

🇧🇪

Aalst, Oost-Vlaanderen, Belgium

UZ Leuven

🇧🇪

Leuven, Vlaams-Brabant, Belgium

AZ Groeninge Campus Kennedylaan

🇧🇪

Kortrijk, West-Vlaanderen, Belgium

Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman

🇧🇪

Liège, Belgium

CEDOES

🇧🇷

Vitória, Espírito Santo, Brazil

Fundação Universidade de Caxias do Sul (FUCS)

🇧🇷

Caxias do sul, Rio Grande Do Sul, Brazil

NewData Clinical Research - Aracaju

🇧🇷

Aracaju, Sergipe, Brazil

Loema Instituto de Pesquisa Clinica

🇧🇷

Campinas, São Paulo, Brazil

CPQuali Pesquisa Clínica

🇧🇷

São Paulo, Brazil

Clínica Hepatogastro JK

🇧🇷

São Paulo, Brazil

(G.I.R.I.) GI Research Institute Foundation

🇨🇦

Vancouver, British Columbia, Canada

SurGal Clinic

🇨🇿

Brno, Brno-město, Czechia

Nemocnice České Budějovice

🇨🇿

České Budějovice, Jihočeský Kraj, Czechia

Krajská nemocnice Liberec

🇨🇿

Turnov, Liberecký Kraj, Czechia

EndoArt

🇨🇿

Ostrava, Moravskoslezský Kraj, Czechia

ResTrial GastroEndo s.r.o

🇨🇿

Prague, Praha 4, Czechia

ISCARE klinické centrum

🇨🇿

Prague, Praha 9, Czechia

Gastroenterologie

🇨🇿

Hradec Králové, Czechia

Masarykova Nemocnice V Usti Nad Labem

🇨🇿

Usti nad Labem, Ústí Nad Labem, Czechia

Rigshospitalet

🇩🇰

Copenhagen, Hovedstaden, Denmark

Herlev and Gentofte Hospital

🇩🇰

Copenhagen, Hovedstaden, Denmark

Aarhus Universitetshospital, Skejby

🇩🇰

Aarhus, Midtjylland, Denmark

Aalborg Universitetshospital, Syd

🇩🇰

Aalborg, Nordjylland, Denmark

Vejle Sygehus

🇩🇰

Vejle, Syddanmark, Denmark

Centre Hospitalier Universitaire de Nice - Hôpital l'Archet

🇫🇷

Nice, Alpes-Maritimes, France

Assistance Publique Hôpitaux de Marseille - Hôpital Nord

🇫🇷

Marseille, Bouches-du-Rhône, France

Clinique Pasteur

🇫🇷

Toulouse, Haute-Garonne, France

CHU Charles Nicolle

🇫🇷

Rouen, Haute-Normandie, France

Clinique des Cèdres

🇫🇷

Échirolles, Isère, France

Chu Saint Eloi

🇫🇷

Montpellier, Languedoc-Roussillon, France

Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre

🇫🇷

Le Kremlin-Bicêtre, Paris, France

Groupe Hospitalier Intercommunal Le Raincy-Montfermeil

🇫🇷

Montfermeil, Paris, France

Centre Hospitalier Universitaire de Saint Étienne - Hôpital Nord

🇫🇷

Saint-Priest-en-Jarez, Rhône-Alpes, France

CHD Vendee

🇫🇷

La Roche-sur-Yon, Vendée, France

Klinikum Ernst von Bergmann

🇩🇪

Potsdam, Brandenburg, Germany

Synexus Clinical Research GmbH Synexus Frankfurt Clinical Research Centre

🇩🇪

Frankfurt am Main, Hessen, Germany

Universitätsklinikum Frankfurt Goethe-Universität

🇩🇪

Frankfurt, Hessen, Germany

Medizinische Hochschule Hannover

🇩🇪

Hannover, Niedersachsen, Germany

Praxiszentrum für Gastroenterologie

🇩🇪

Grevenbroich, Nordrhein-Westfalen, Germany

Studiengesellschaft BSF Unternehmergesellschaft

🇩🇪

Halle (Saale), Sachsen-Anhalt, Germany

Eugastro GmbH

🇩🇪

Leipzig, Sachsen, Germany

Evangelismos General Hospital of Athens

🇬🇷

Athens, Attikí, Greece

Thoracic General Hospital of Athens "I Sotiria"

🇬🇷

Athens, Attikí, Greece

University Hospital of Ioannina

🇬🇷

Ioannina, Ioánnina, Greece

Ippokrateio General Hospital of Thessaloniki

🇬🇷

Thessaloniki, Kentrikí Makedonía, Greece

University General Hospital of Heraklion

🇬🇷

Heraklion, Krítí, Greece

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ

🇭🇺

Szeged, Csongrád, Hungary

CLINFAN Szolgáltató Kft

🇭🇺

Szekszárd, Tolna, Hungary

Semmelweis Egyetem

🇭🇺

Budapest, Hungary

Assuta Ashdod Medical Center

🇮🇱

Ashdod, HaDarom, Israel

Edith Wolfson Medical Center

🇮🇱

Holon, HaMerkaz, Israel

Rabin Medical Center

🇮🇱

Petah Tikva, HaMerkaz, Israel

Sheba Medical Center

🇮🇱

Ramat Gan, HaMerkaz, Israel

Yitzhak Shamir Medical Center

🇮🇱

Zerifin, HaMerkaz, Israel

Rambam Health Care Campus

🇮🇱

Haifa, HaTsafon, Israel

Sourasky Medical Center

🇮🇱

Tel Aviv, Tell Abīb, Israel

Shaare Zedek Medical Center

🇮🇱

Jerusalem, Yerushalayim, Israel

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola

🇮🇹

Bologna, Emilia-Romagna, Italy

Fondazione Policlinico Universitario Agostino Gemelli

🇮🇹

Roma, Lazio, Italy

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

🇮🇹

Milano, Lombardia, Italy

Humanitas

🇮🇹

Rozzano, Lombardia, Italy

Ospedale Di Circolo

🇮🇹

Rho, Milano, Italy

Ospedale Specializzato in Gastroenterologia "Saverio de Bellis"

🇮🇹

Castellana Grotte, Puglia, Italy

Az. Osp. Ospedali Riuniti VILLA SOFIA-CERVELLO

🇮🇹

Palermo, Sicilia, Italy

Azienda Ospedaliero Universitaria Pisana

🇮🇹

Pisa, Toscana, Italy

Azienda Ospedale - Università Padova

🇮🇹

Padova, Veneto, Italy

Ospedale San Raffaele

🇮🇹

Milano, Italy

Boca Clinical Trials Mexico S.C.

🇲🇽

Guadajalara, Jalisco, Mexico

Servicios de Oncología Médica Integral - Monterrey

🇲🇽

Monterrey, Nuevo León, Mexico

Health Pharma Querétaro

🇲🇽

Juriquilla, Querétaro, Mexico

Scientia Investigacion Clinica S.C.

🇲🇽

Chihuahua, Mexico

Centro de Investigación Clinica Chapultepec

🇲🇽

Mexico City, Mexico

Amsterdam UMC, locatie VUmc

🇳🇱

Amsterdam, Noord-Holland, Netherlands

Erasmus Medisch Centrum

🇳🇱

Rotterdam, Zuid-Holland, Netherlands

Ikazia Ziekenhuis

🇳🇱

Rotterdam, Zuid-Holland, Netherlands

Universitair Medisch Centrum Utrecht

🇳🇱

Utrecht, Netherlands

Melita Medical

🇵🇱

Wroclaw, Dolnośląskie, Poland

Medrise Sp. z o.o.

🇵🇱

Lublin, Lubelskie, Poland

ETG Zamość

🇵🇱

Zamość, Lubelskie, Poland

NZOZ GynCentrum - Oddział Warszawa

🇵🇱

Warsaw, Mazowieckie, Poland

Vivamed Sp. z o.o.

🇵🇱

Warszawa, Mazowieckie, Poland

Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś

🇵🇱

Warszawa, Mazowieckie, Poland

Korczowski Bartosz, Gabinet Lekarski

🇵🇱

Rzeszów, Podkarpackie, Poland

Uniwersyteckie Centrum Stomatologii i Medycyny Specjalistycznej

🇵🇱

Poznan, Wielkopolskie, Poland

Twoja Przychodnia PCM

🇵🇱

Poznań, Wielkopolskie, Poland

Twoja Przychodnia SCM

🇵🇱

Szczecin, Zachodniopomorskie, Poland

IRMED

🇵🇱

Piotrkow Trybunalski, Łódzkie, Poland

Spitalul Județean de Urgență Bacău

🇷🇴

Bacau, Bacău, Romania

Spitalul Clinic Colentina

🇷🇴

Bucuresti, București, Romania

Constanta County Emergency Clinical Hospital Sf.Ap.Andrei

🇷🇴

Constanta, Constanța, Romania

Spitalul Clinic Județean de Urgență

🇷🇴

Craiova, Dolj, Romania

S.C Centrul de Gastroenterologie Dr. Goldis S.R.L

🇷🇴

Timisoara, Timiș, Romania

Spitalul Universitar de Urgență București

🇷🇴

București, Romania

Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica

🇸🇰

Banska Bystrica, Banskobystrický Kraj, Slovakia

Cliniq s.r.o.

🇸🇰

Bratislava, Bratislavský Kraj, Slovakia

ENDOMED

🇸🇰

Kosice, Košický Kraj, Slovakia

Gastro LM

🇸🇰

Presov, Slovakia

Hospital de Cabueñes

🇪🇸

Gijón, Asturias, Spain

Hospital Universitario Central de Asturias

🇪🇸

Oviedo, Asturias, Spain

Centro Médico Teknon

🇪🇸

Barcelona, Barcelona [Barcelona], Spain

Hospital Universitari Vall d'Hebron

🇪🇸

Barcelona, Barcelona [Barcelona], Spain

Hospital Galdakao-Usansolo

🇪🇸

Galdakao, Bizkaia, Spain

Complejo Hospitalario de Navarra

🇪🇸

Pamplona, Navarra, Spain

Hospital General Universitario Gregorio Marañon

🇪🇸

Madrid, Spain

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

Hospital Universitario Virgen Macarena

🇪🇸

Sevilla, Spain

Hospital Universitari i Politecnic La Fe

🇪🇸

València, Spain

Eskisehir Osmangazi University

🇹🇷

Eskisehir, Eskişehir, Turkey

Kocaeli University Medical Faculty Hospital

🇹🇷

Izmit, Kocaeli, Turkey

Antalya Egitim ve Arastırma Hastanesi

🇹🇷

Antalya, Turkey

Uludag Universitesi

🇹🇷

Bursa, Turkey

Mustafa Kemal Universitesi

🇹🇷

Hatay, Turkey

Bezmialem Vakf Üniversitesi

🇹🇷

Istanbul, Turkey

Ege Universitesi Hastanesi

🇹🇷

İzmir, Turkey

Mersin University

🇹🇷

Mersin, Turkey

© Copyright 2025. All Rights Reserved by MedPath